The Nifty remained sluggish in afternoon ahead of expiry of March futures & options contracts. Investors awaited March quarter earnings due next month that will give direction to the market.
The 30-share BSE Sensex was up 38.27 points at 29,569.70 and the 50-share NSE Nifty gained 7.65 points at 9,151.45. The broader markets continued to outperform benchmarks, with the Nifty Midcap rising 0.3 percent.
Kotak Mahindra Bank gained over a percent on fundraising plan by diluting Uday Kotak's stake while Aurobindo Pharma was up 1 percent as it has received final approval from the US health regulator to manufacture abacavir sulfate and lamivudine tablets, used in the treatment of HIV.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
The 30-share BSE Sensex was up 38.27 points at 29,569.70 and the 50-share NSE Nifty gained 7.65 points at 9,151.45. The broader markets continued to outperform benchmarks, with the Nifty Midcap rising 0.3 percent.
Kotak Mahindra Bank gained over a percent on fundraising plan by diluting Uday Kotak's stake while Aurobindo Pharma was up 1 percent as it has received final approval from the US health regulator to manufacture abacavir sulfate and lamivudine tablets, used in the treatment of HIV.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
No comments:
Post a Comment